Compagnie de Saint-Gobain S.A. (LON:COD - Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 96.42 ($1.30) and traded as high as GBX 97.70 ($1.31). Compagnie de Saint-Gobain shares last traded at GBX 92.57 ($1.24), with a volume of 315,244 shares.
Compagnie de Saint-Gobain Price Performance
The company has a debt-to-equity ratio of 70.84, a quick ratio of 0.82 and a current ratio of 1.41. The stock has a market cap of £450.67 million, a PE ratio of 16.08, a PEG ratio of 2.72 and a beta of 1.39. The stock has a 50 day moving average of GBX 97.85 and a two-hundred day moving average of GBX 96.32.
Compagnie de Saint-Gobain Company Profile
(
Get Free Report)
Compagnie de Saint-Gobain SA designs, manufactures, and distributes materials and solutions for the construction and industrial markets worldwide. It operates through five segments: High Performance Solutions; Northern Europe; Southern Europe Middle East (ME) & Africa; Americas; and Asia-Pacific.
Further Reading
Before you consider Compagnie de Saint-Gobain, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Compagnie de Saint-Gobain wasn't on the list.
While Compagnie de Saint-Gobain currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.